SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-104535
Filing Date
2015-03-25
Accepted
2015-03-25 11:59:35
Documents
13
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F d862375d20f.htm 20-F 1341227
2 EX-4.18 d862375dex418.htm EX-4.18 469190
3 EX-12.1 d862375dex121.htm EX-12.1 7378
4 EX-12.2 d862375dex122.htm EX-12.2 7359
5 EX-13.1 d862375dex131.htm EX-13.1 5794
6 EX-15.1 d862375dex151.htm EX-15.1 2535
7 GRAPHIC g862375g04d08.jpg GRAPHIC 60059
8 GRAPHIC g862375g24w42.jpg GRAPHIC 111909
9 GRAPHIC g862375g66e07.jpg GRAPHIC 175493
10 GRAPHIC g862375g66u65.jpg GRAPHIC 77155
11 GRAPHIC g862375g84d52.jpg GRAPHIC 112809
12 GRAPHIC g862375g88k69.jpg GRAPHIC 64629
13 GRAPHIC g862375g96k08.jpg GRAPHIC 113413
  Complete submission text file 0001193125-15-104535.txt   2821270
Mailing Address 6 JONATHAN NETANYAHU ST. OR YEHUDA L3 60376
Business Address 6 JONATHAN NETANYAHU ST. OR YEHUDA L3 60376 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36581 | Film No.: 15723932
SIC: 2834 Pharmaceutical Preparations